RN7SKP46

Across TCGA pan-cancer cohorts, RN7SKP46 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RN7SKP46 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RN7SKP46 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SKP46 expression acts as an unfavorable survival marker.

LUAD, KIRC, and OV are the cancer types where RN7SKP46 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.141	0.788	<.001	63	view →
KIRC	DFS	Tertile	All	0.224	0.799	<.001	54	view →
OV	OS	Tertile	II,III,IV	0.603	0.846	.016	48	view →
KIRP	OS	Tertile	II,III,IV	0.176	0.743	.007	36	view →
HNSC	OS	Tertile	III,IV	0.086	0.674	.004	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RN7SKP46–LUAD (OS)

Open the LUAD breakdown →